Event Brief
Nov 16, 2025 at 9:02 AM ET
Why are biologic drugs expensive?
By The BriefBrief
FDA aims to speed biosimilar approvals, but prices may not drop quickly.
WHO: FDA, experts
WHAT: Discussion on biologic drug pricing and biosimilar approvals
WHEN: Nov 15, 2025 at 7:00 PM ET
WHERE: United States
WHY: To increase competition in the drug market
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21417 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
